{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:07:33Z","timestamp":1789056453217,"version":"build-2803163510"},"reference-count":123,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA136393"],"award-info":[{"award-number":["P50CA136393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24OD026641"],"award-info":[{"award-number":["U24OD026641"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01CA254849"],"award-info":[{"award-number":["P01CA254849"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI146009"],"award-info":[{"award-number":["R01AI146009"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA232561"],"award-info":[{"award-number":["U54CA232561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA077598"],"award-info":[{"award-number":["P30CA077598"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA268069"],"award-info":[{"award-number":["U54CA268069"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002086","name":"Fanconi Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013187","name":"Randy Shaver Cancer Research and Community Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000885","name":"Children's Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["HT9425-24-1-0231"],"award-info":[{"award-number":["HT9425-24-1-0231"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["HT9425-24-1-1002"],"award-info":[{"award-number":["HT9425-24-1-1002"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of War","doi-asserted-by":"publisher","award":["HT9425-24-1-1005"],"award-info":[{"award-number":["HT9425-24-1-1005"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["110411"],"award-info":[{"award-number":["110411"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI161017"],"award-info":[{"award-number":["R01AI161017"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201778","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:40:55Z","timestamp":1781160055000},"page":"201778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["NK cell immunotherapy after analytic treatment interruption is associated with HIV viral control"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3867-6448","authenticated-orcid":false,"given":"Liliana K.","family":"Thron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongthorn","family":"Pumtang-on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Woong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell E.","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Gorrell-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsie L.","family":"Becklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe E.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad F.","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron K.","family":"Rendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Pampusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia A.","family":"Casares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaiva","family":"Vezys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branden S.","family":"Moriarity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201778_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.trsl.2017.06.011","article-title":"Chimeric antigen receptor T-cells for B-cell malignancies","volume":"187","author":"Lichtman","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.omta.2026.201778_bib3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","article-title":"The Principles of Engineering Immune Cells to Treat Cancer","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201778_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature22395","article-title":"Therapeutic T cell engineering","volume":"545","author":"Sadelain","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201778_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nm.4015","article-title":"Prospects for gene-engineered T cell immunotherapy for solid cancers","volume":"22","author":"Klebanoff","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201778_bib6","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/apc.2016.0239","article-title":"Engineering HIV-Specific Immunity with Chimeric Antigen Receptors","volume":"30","author":"Kitchen","year":"2016","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.omta.2026.201778_bib7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jcyt.2016.04.007","article-title":"T-cell therapies for HIV: Preclinical successes and current clinical strategies","volume":"18","author":"Patel","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omta.2026.201778_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1089\/apc.2016.0226","article-title":"Combining Cell and Gene Therapy in an Effort to Eradicate HIV","volume":"30","author":"Wagner","year":"2016","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.omta.2026.201778_bib9","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/infdis\/jix002","article-title":"Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir","volume":"215","author":"Riley","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omta.2026.201778_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcyt.2017.11.001","article-title":"Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity","volume":"20","author":"Ghanem","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omta.2026.201778_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fimmu.2018.00492","article-title":"Simian immunodeficiency virus (SIV)-specific chimeric antigen receptor-T cells engineered to target B cell follicles and suppress SIV replication","volume":"9","author":"Haran","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-0716-1944-5_12","article-title":"Production and characterization of SIV-specific CAR\/CXCR5 T cells","volume":"2421","author":"Pampusch","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omta.2026.201778_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/362355a0","article-title":"HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease","volume":"362","author":"Pantaleo","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201778_bib14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/377740a0","article-title":"Follicular dendritic cells and human immunodeficiency virus infectivity","volume":"377","author":"Heath","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201778_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/362359a0","article-title":"Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS","volume":"362","author":"Embretson","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201778_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/aid.2005.21.363","article-title":"Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms","volume":"21","author":"Folkvord","year":"2005","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.omta.2026.201778_bib17","first-page":"217","article-title":"Lymphadenopathy in HIV (HTLV-III\/LAV) infected subjects: the role of virus and follicular dendritic cells","volume":"12","author":"Biberfeld","year":"1988","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.omta.2026.201778_bib18","first-page":"9","article-title":"HTLV-III\/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS","volume":"123","author":"Tenner-Racz","year":"1986","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omta.2026.201778_bib19","first-page":"16","article-title":"Follicular dendritic cells in HIV-induced lymphadenopathy and AIDS","volume":"8","author":"Racz","year":"1989","journal-title":"APMIS Suppl."},{"key":"10.1016\/j.omta.2026.201778_bib20","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.4049\/jimmunol.1401161","article-title":"Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL","volume":"193","author":"Connick","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009831","article-title":"CAR\/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection","volume":"18","author":"Pampusch","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omta.2026.201778_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40164-025-00633-8","article-title":"The clinical landscape of CAR NK cells","volume":"14","author":"J\u00f8rgensen","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.omta.2026.201778_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030264","article-title":"Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells","volume":"7","author":"Denman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201778_bib24","author":"Fujisaki"},{"key":"10.1016\/j.omta.2026.201778_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","article-title":"NK cell-based immunotherapy for malignant diseases","volume":"10","author":"Cheng","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib26","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1158\/1078-0432.CCR-13-1766","article-title":"Infusions of allogeneic natural killer cells as cancer therapy","volume":"20","author":"Leung","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omta.2026.201778_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00262-014-1614-z","article-title":"Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients","volume":"64","author":"Peragine","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omta.2026.201778_bib28","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1073\/pnas.2336091100","article-title":"Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates","volume":"100","author":"Mavilio","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201778_bib29","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/eji.200737217","article-title":"Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1","volume":"37","author":"Harada","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib30","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-222190","article-title":"NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects","volume":"115","author":"Olson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201778_bib31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jcyt.2021.03.006","article-title":"Infusion reactions in natural killer cell immunotherapy: a retrospective review","volume":"23","author":"Mamo","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omta.2026.201778_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108212","article-title":"Non-viral engineering of NK cells","volume":"68","author":"Hinnekens","year":"2023","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.omta.2026.201778_bib33","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: Development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000324176","article-title":"Natural killer cell responses to viral infection","volume":"3","author":"Brandstadter","year":"2011","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.omta.2026.201778_bib35","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.4049\/jimmunol.171.11.5663","article-title":"Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users","volume":"171","author":"Scott-Algara","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib36","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1073\/pnas.071548198","article-title":"Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity","volume":"98","author":"Flores-Villanueva","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201778_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10237","article-title":"HIV-1 adaptation to NK-cell-mediated immune pressure","volume":"476","author":"Alter","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201778_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001900","article-title":"Selection of an HLA-C\u221703:04-restricted HIV-1 p24 Gag sequence variant is associated with viral escape from KIR2DL3+ natural killer cells: Data from an observational cohort in South Africa","volume":"12","author":"H\u00f6lzemer","year":"2015","journal-title":"PLoS Med."},{"key":"10.1016\/j.omta.2026.201778_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2017.22","article-title":"NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147","volume":"6","author":"Gondois-Rey","year":"2017","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.omta.2026.201778_bib40","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3389\/fimmu.2017.01176","article-title":"NKG2C+NKG2A- natural killer cells are associated with a lower viral set point and may predict disease progression in individuals with primary HIV infection","volume":"8","author":"Ma","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omta.2026.201778_bib42","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1097\/QAD.0000000000001645","article-title":"Natural killer cells in HIV-1 infection and therapy","volume":"31","author":"Mikulak","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.omta.2026.201778_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.2008.02045.x","article-title":"NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection","volume":"265","author":"Alter","year":"2009","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.omta.2026.201778_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5722","article-title":"Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility","volume":"7","author":"Strauss-Albee","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omta.2026.201778_bib45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","article-title":"NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy","volume":"6","author":"Wang","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.879124","article-title":"Natural Killer cells in antibody independent and antibody dependent HIV control","volume":"13","author":"Bernard","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib47","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/infdis\/jiad578","article-title":"Safety and virologic impact of haploidentical NK cells plus interleukin 2 or N-803 in HIV infection","volume":"229","author":"Miller","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.omta.2026.201778_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41467-021-27647-0","article-title":"Latency reversal plus natural killer cells diminish HIV reservoir in vivo","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omta.2026.201778_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jimmun\/vkae028","article-title":"Gene-modified NK cells expressing CD64 and preloaded with HIV-specific BNAbs target autologous HIV-1-infected CD4+ T cells by ADCC","volume":"214","author":"Tomescu","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib50","article-title":"NK cells engineered with a chimeric antigen receptor delay HIV rebound and reshape HIV reservoir composition","author":"Shi","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.omta.2026.201778_bib51","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cyto.2011.09.028","article-title":"IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization","volume":"56","author":"Han","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.omta.2026.201778_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ymthe.2019.10.009","article-title":"A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy","volume":"28","author":"Pomeroy","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201778_bib53","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ymthe.2024.04.024","article-title":"Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies","volume":"32","author":"Skeate","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201778_bib54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/2326-6066.CIR-17-0207","article-title":"Intrinsic functional potential of NK-cell subsets constrains retargeting driven by chimeric antigen receptors","volume":"6","author":"Oei","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omta.2026.201778_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41420-024-01815-9","article-title":"Breakthrough of solid tumor treatment: CAR-NK immunotherapy","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.omta.2026.201778_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omta.2026.201778_bib57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/asheducation-2013.1.247","article-title":"Therapeutic applications: natural killer cells in the clinic","volume":"2013","author":"Miller","year":"2013","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.omta.2026.201778_bib58","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/acschembio.0c00537","article-title":"A universal CAR-NK cell targeting various epitopes of HIV-1 gp160","volume":"15","author":"Lim","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omta.2026.201778_bib59","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/stem.1611","article-title":"Expression of chimeric receptor CD4\u03b6 by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo: Pluripotent stem cell-derived NK cells for HIV therapy","volume":"32","author":"Ni","year":"2014","journal-title":"Stem Cell."},{"key":"10.1016\/j.omta.2026.201778_bib60","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mt.2015.102","article-title":"HIV-specific immunity derived from chimeric antigen receptor-engineered stem cells","volume":"23","author":"Zhen","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201778_bib61","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/nm.4421","article-title":"Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys","volume":"23","author":"Huot","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201778_bib62","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155601","article-title":"Lymph node CXCR5+ NK cells associate with control of chronic SHIV infection","volume":"7","author":"Rahman","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.omta.2026.201778_bib63","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1128\/JVI.77.4.2736-2740.2003","article-title":"Expression of the major histocompatibility complex class I molecule Mamu-A\u221701 is associated with control of simian immunodeficiency virus SIVmac239 replication","volume":"77","author":"Moth\u00e9","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201778_bib64","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/00002030-200207260-00005","article-title":"SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans","volume":"16","author":"Ling","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.omta.2026.201778_bib65","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.4049\/jimmunol.156.12.4656","article-title":"The MHC class I genes of the rhesus monkey. Different evolutionary histories of MHC class I and II genes in primates","volume":"156","author":"Boyson","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib66","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1073\/pnas.0409084102","article-title":"Unparalleled complexity of the MHC class I region in rhesus macaques","volume":"102","author":"Otting","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2026.201778_bib67","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.274.5289.985","article-title":"Quantitative image analysis of HIV-1 infection in lymphoid tissue","volume":"274","author":"Haase","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.omta.2026.201778_bib68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/microorganisms12010155","article-title":"The Impact and Effects of Host Immunogenetics on Infectious Disease Studies Using Non-Human Primates in Biomedical Research","volume":"12","author":"Berry","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.omta.2026.201778_bib69","first-page":"23","article-title":"Use of humanized mouse models for studying HIV-1 infection, pathogenesis and persistence","volume":"2","author":"Weichseldorfer","year":"2020","journal-title":"J. AIDS HIV Treat."},{"key":"10.1016\/j.omta.2026.201778_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/srep28093","article-title":"Differential effect of HLA class-I versus class-II transgenes on human T and B cell reconstitution and function in NRG mice","volume":"6","author":"Majji","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201778_bib71","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12936-018-2264-y","article-title":"Humanized DRAGA mice immunized with Plasmodium falciparum sporozoites and chloroquine elicit protective pre-erythrocytic immunity","volume":"17","author":"Majji","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.omta.2026.201778_bib72","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/21645515.2017.1403703","article-title":"Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model","volume":"14","author":"Mendoza","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omta.2026.201778_bib73","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/v14091927","article-title":"Comparing Current and Next-Generation Humanized Mouse Models for Advancing HIV and HIV\/Mtb Co-Infection Studies","volume":"14","author":"Lepard","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201778_bib74","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3389\/fimmu.2018.00816","article-title":"Dissemination of Orientia tsutsugamushi, a Causative Agent of Scrub Typhus, and Immunological Responses in the Humanized DRAGA Mouse","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib75","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1080\/21645515.2020.1713605","article-title":"The humanized DRAGA mouse (HLA-A2. HLA-DR4. RAG1 KO. IL-2R g c KO. NOD) establishes inducible and transmissible models for influenza type A infections","volume":"16","author":"Mendoza","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omta.2026.201778_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1047277","article-title":"HIV-1 infected humanized DRAGA mice develop HIV-specific antibodies despite lack of canonical germinal centers in secondary lymphoid tissues","volume":"13","author":"Ollerton","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib77","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2048622","article-title":"Human-Immune-System (HIS) humanized mouse model","volume":"18","author":"Brumeanu","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omta.2026.201778_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/jimmun\/vkaf185","article-title":"Humanized DRAGA mice are a valuable model to study novel immunotherapies for HIV-1","volume":"214","author":"Pumtang-On","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib79","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/v15091912","article-title":"IL-15 and N-803 for HIV cure approaches","volume":"15","author":"Howard","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201778_bib80","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","article-title":"Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.886931","article-title":"Burgeoning exploration of the role of natural killer cells in anti-PD-1\/PD-L1 therapy","volume":"13","author":"Bai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.765705","article-title":"Making a killer: Selecting the optimal natural killer cells for improved immunotherapies","volume":"12","author":"Barnes","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib83","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009560","article-title":"Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omta.2026.201778_bib84","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti\u2013PD-1 antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201778_bib85","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3390\/cancers12113285","article-title":"The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function and Targeting in Tumour Immunotherapy","volume":"12","author":"Quatrini","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.omta.2026.201778_bib86","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/vim.2011.0096","article-title":"PD-1 expression on natural killer cells and CD8(+) T cells during chronic HIV-1 infection","volume":"25","author":"Norris","year":"2012","journal-title":"Viral Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib87","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4049\/jimmunol.2000054","article-title":"Early T cell activation metrics predict graft-versus-host disease in a humanized mouse model of hematopoietic stem cell transplantation","volume":"205","author":"Hess","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib88","series-title":"CD4 Cell Count and HIV","author":"Battistini Garcia","year":"2025"},{"key":"10.1016\/j.omta.2026.201778_bib89","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers","volume":"21","author":"Fukazawa","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201778_bib90","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2016.08.018","article-title":"CD8(+) lymphocytes are required for maintaining viral suppression in SIV-infected macaques treated with short-term antiretroviral therapy","volume":"45","author":"Cartwright","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.omta.2026.201778_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-1946-0","article-title":"Author Correction: Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells","volume":"578","author":"McBrien","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201778_bib92","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni845","article-title":"HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors","volume":"3","author":"Migueles","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib93","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","article-title":"Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control","volume":"29","author":"Migueles","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.omta.2026.201778_bib94","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1172\/JCI136886","article-title":"The immune response fails to control HIV early in initial virus spread","volume":"130","author":"Cohn","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201778_bib95","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1128\/JVI.01153-09","article-title":"Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy","volume":"83","author":"Migueles","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201778_bib96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/bloodadvances.2017012971","article-title":"The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles","volume":"2","author":"Webb","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.omta.2026.201778_bib97","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1038\/s41598-018-25987-4","article-title":"Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy","volume":"8","author":"Hu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201778_bib98","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jcyt.2020.09.009","article-title":"Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma","volume":"23","author":"Tschan-Plessl","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.omta.2026.201778_bib99","first-page":"250.e1","article-title":"A Phase I study to determine the maximum tolerated dose of ex vivo expanded natural killer cells derived from unrelated, HLA-disparate adult donors. Transplant","volume":"28","author":"Otegbeye","year":"2022","journal-title":"Cell. Ther."},{"key":"10.1016\/j.omta.2026.201778_bib100","article-title":"Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma","volume":"3","author":"Nahi","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.omta.2026.201778_bib101","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211986","article-title":"Insights into mechanisms of graft-versus-host disease through humanised mouse models","volume":"42","author":"Elhage","year":"2022","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.omta.2026.201778_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2023.06.221","article-title":"3114 \u2013 sex dimorphism in the bone marrow niche contributes to gender difference in mouse hematopoiesis","volume":"124","author":"Cui","year":"2023","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omta.2026.201778_bib103","doi-asserted-by":"crossref","first-page":"13259","DOI":"10.1128\/JVI.01353-07","article-title":"Humanized NOD\/SCID\/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis","volume":"81","author":"Watanabe","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.omta.2026.201778_bib104","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3324\/haematol.2016.147645","article-title":"Donor and recipient sex in allogeneic stem cell transplantation: what really matters","volume":"101","author":"Kim","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.omta.2026.201778_bib105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.tp.0000226156.99206.d1","article-title":"Influence of donor\/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia","volume":"82","author":"Stern","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.omta.2026.201778_bib106","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bbmt.2020.05.001","article-title":"Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide","volume":"26","author":"Im","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omta.2026.201778_bib107","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.166.11.6477","article-title":"Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire","volume":"166","author":"Campbell","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib108","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/v16020219","article-title":"Examining chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection","volume":"16","author":"Mu","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.omta.2026.201778_bib109","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","article-title":"Systemic effects of inflammation on health during chronic HIV infection","volume":"39","author":"Deeks","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.omta.2026.201778_bib110","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.4049\/jimmunol.179.8.5099","article-title":"Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation","volume":"179","author":"Haynes","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib111","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood-2004-03-1206","article-title":"Unique gene expression program of human germinal center T helper cells","volume":"104","author":"Kim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201778_bib112","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1084\/jem.193.12.1373","article-title":"Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells","volume":"193","author":"Kim","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omta.2026.201778_bib113","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2011-11-389924","article-title":"Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7","volume":"119","author":"Somanchi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201778_bib114","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41698-024-00595-w","article-title":"Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity","volume":"8","author":"Sanz-Ortega","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.omta.2026.201778_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/acg2.27","article-title":"Targeting reservoirs of HIV replication in lymphoid follicles with cellular therapies to cure HIV","volume":"2","author":"Skinner","year":"2019","journal-title":"Adv. Cell Gene Ther."},{"key":"10.1016\/j.omta.2026.201778_bib116","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.immuni.2018.04.030","article-title":"Targeting the Latent Reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.omta.2026.201778_bib117","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fcimb.2020.00410","article-title":"Engineering CAR T cells to target the HIV reservoir","volume":"10","author":"Mu","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omta.2026.201778_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.842746","article-title":"Targeting NK cells for HIV-1 treatment and reservoir clearance","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omta.2026.201778_bib119","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1182\/blood.V128.22.2517.2517","article-title":"A novel HIV envelope bi-specific killer engager enhances Natural Killer cell mediated ADCC responses against HIV-infected cells","volume":"128","author":"Davis","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.omta.2026.201778_bib121","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2125.2010.03735.x","article-title":"Potential use of rapamycin in HIV infection","volume":"70","author":"Donia","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.omta.2026.201778_bib122","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185489","article-title":"Rapamycin enhances CAR-T control of HIV replication and reservoir elimination in vivo","volume":"135","author":"Mu","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2026.201778_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2019.09.007","article-title":"Rapid Transduction and Expansion of Transduced T Cells with Maintenance of Central Memory Populations","volume":"16","author":"Pampusch","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201778_bib124","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/s41591-020-1039-5","article-title":"Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo","volume":"26","author":"Maldini","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2026.201778_bib125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12977-016-0268-7","article-title":"In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection","volume":"13","author":"Tsai","year":"2016","journal-title":"Retrovirology"}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:17:39Z","timestamp":1789053459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":123,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001138"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201778","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NK cell immunotherapy after analytic treatment interruption is associated with HIV viral control","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201778"}}